Skip to content

GYNEMESH PS Mesh Post Marketing Clinical Follow-Up Study

A Retrospective and Long-Term Prospective Post Market Clinical Follow-up (PMCF) Study of the GYNECARE GYNEMESH® PS Nonabsorbable PROLENE® Soft Mesh

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04829058
Enrollment
64
Registered
2021-04-02
Start date
2021-11-24
Completion date
2026-06-24
Last updated
2026-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic Organ Prolapse

Keywords

GYNECARE GYNEMESH® PS Nonabsorbable PROLENE® Soft Mesh, POP

Brief summary

The objective of this retrospective and prospective, single-arm, observational, multicenter, post-market study is to evaluate outcomes in women who underwent surgery for vaginal or uterine prolapse with a GYNEMESH PS Mesh.

Interventions

DEVICEIntervention

There is no intervention, beyond necessary clinical care, in this study. The surgical procedures that were performed in subjects within this study are identical to the surgical procedures the subjects would have received as part of SOC.

Sponsors

Ethicon, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Subjects who satisfy all of the following criteria will be considered eligible for enrollment in this study: 1. Female subjects who had laparotomic or laparoscopic abdominal sacrocolpopexy, including robotic-assisted, for apical vaginal or uterine prolapse 2. GYNEMESH PS Mesh was used as a bridging material according to the IFU. 3. Able and willing to participate in follow-up 4. Subject or authorized representative has signed the approved informed consent

Exclusion criteria

Subjects meeting any of the following criteria will be considered not eligible for enrollment in this study: 1. Subjects \< 21 years of age at the time of informed consent 2. Subjects who had transvaginal approach for surgery 3. Had undergone a uterus-sparing procedure (sacrohystero or sacrocervicopexy)

Design outcomes

Primary

MeasureTime frameDescription
Physical examination with Pelvic Organ Prolapse Quantification (POP-Q) Assessment CHangePost-surgery through study completion, approximately 7 yrsObjective cure of vaginal or uterine prolapse approximately 7 years after surgery, defined as POP-Q stage ≤2 at point C as determined with physical exam.

Secondary

MeasureTime frame
Patient Global Impression of Improvement (PGI-I) or Patient Global Impression of Change (PGI-C) QuestionnairePost-surgery through study completion, approximately 7yrs
Pelvic Floor Distress Inventory (PFDI-20) QuestionnairePost-surgery through study completion, approximately 7yrs
Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12) or Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire, IUGA-Revised (PISQ-IR)Post-surgery through study completion, approximately 7yrs

Countries

Germany, United States

Contacts

STUDY_DIRECTORMartin Weisberg, MD

Ethicon, Inc.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 12, 2026